FEATURED ARTICLE

Regulatory Compliance in Dermatology and Clinical Trials

Introduction : Regulatory Compliance in Dermatology and Clinical Trials Clinical trials are essential to create the novel medical cures and treatments. They produce vital information that aids pharmaceutical firms in introducing novel medications to the market. Clinical trials are scientific investigations designed to evaluate the safety and efficacy of novel therapies or interventions. These trials

Clinical Trials Articles

Clinical Trials |
Medical Devices |
Phytopharmaceutical Clinical Trials: What Makes Them Different?

Developing plant-based medicines involves bringing traditional knowledge together with modern scientific evidence. Phytopharmaceutical Clinical Trials come with their own challenges, particularly around chemical standardization, safety assessment, and regulatory compliance. Unlike crude herbal products or isolated compounds, phytopharmaceuticals are based on standardized fractions with defined active chemical markers. This makes them a distinct category that connects

Clinical Trials |
Fixed Dose Combination (FDC) Clinical Trials in India: Regulatory Requirements

FDC Clinical Trials in India require a clear therapeutic rationale, appropriate clinical evidence, CDSCO review, and chemical and Pharmaceutical information to demonstrate the safety, quality and suitability of the fixed dose combination for use. FDC Clinical Trials in India Fixed Dose Combinations (FDCs) are medicines that contain two or more active ingredients intended to treat

Clinical Trials |
Drug |
Navigating CDSCO Regulations: A Complete Guide to Clinical Trial Approvals in India

Clinical Trials in India must follow a structured regulatory process to ensure ethical conduct, participant safety, and data reliability. Compliance with the CDSCO approval process, Ethics Committee requirements, and the New Drugs and Clinical Trials Rules, 2019 is essential before a trial can begin. Proper documentation and timely regulatory submissions help facilitate the review process

Drug Articles

Drug |
End-to-End Clinical Research Services: How a CRO Supports Drug Development Process from Phase I to Market

Clinical Research Services support every stage of Drug development, from study planning and trial management to regulatory submissions and post-marketing activities. Contract Research Organisations bring to the table their expertise in Clinical Trial execution, biostatistics and data management, regulatory affairs, patient recruitment, and pharmacovigilance. These services help sponsors conduct clinical research timely and efficiently while

Phase 1 Trial
Phase 2 Trial
Phase 3 Trial
Clinical Study Report

Biologicals Articles

Biologicals |
Clinical Trials |
Diagnostic Kits |
Drug |
Medical Devices |
Understanding Informed Consent in Clinical Research

Informed consent in clinical research is a cornerstone of ethical regulatory compliance. It ensures that participants voluntarily decide whether to take part in a study after receiving adequate information about its purpose, procedures, risks, benefits, and alternatives. It is an ongoing process that promotes transparency, protects participants’ rights, and supports autonomous decision-making. Introduction Informed consent

Biologicals |
Clinical Trials |
CDSCO Guidelines for Biological Clinical Trials in India (NDCT Rules 2019)

CDSCO Guidelines for Biological Clinical Trials in India (NDCT Rules 2019) define a structured regulatory pathway for evaluating biologics through phased human studies. The framework ensures safety, quality, and efficacy through strict documentation, ethical approval, GCP compliance, and scientific review. It supports safe development of vaccines, gene therapies, and other biologics before market authorization in

Biologicals |
Clinical Trials |
Regulatory Strategy for Biological & Vaccine Clinical Trials in India

Conducting biologics, biosimilar, and vaccine clinical trials in India requires careful alignment with regulatory requirements throughout the development lifecycle. Sponsors must generate robust preclinical data, obtain regulatory approvals through the Central Drugs Standard Control Organization (CDSCO), and conduct phased clinical trials to demonstrate safety, immunogenicity, and efficacy. While challenges such as variability in immune responses,

Diagnostic Kits Articles

Biologicals |
Clinical Trials |
Diagnostic Kits |
Drug |
Medical Devices |
Understanding Informed Consent in Clinical Research

Informed consent in clinical research is a cornerstone of ethical regulatory compliance. It ensures that participants voluntarily decide whether to take part in a study after receiving adequate information about its purpose, procedures, risks, benefits, and alternatives. It is an ongoing process that promotes transparency, protects participants’ rights, and supports autonomous decision-making. Introduction Informed consent

Diagnostic Kits |
Ensuring Success in Clinical Performance Evaluation for IVDs: Strategies for Sponsors

Ensuring Success in Clinical Performance Evaluation for IVDs: Strategies for Sponsors Summary In healthcare, in vitro diagnostics (IVDs) play a vital role in diagnosing diseases and monitoring treatment effectiveness. However, before these crucial diagnostics can reach patients and healthcare providers, they must undergo clinical performance evaluation to ensure their safety and efficacy. The regulatory process

Diagnostic Kits |
Understanding the Importance of Clinical Performance Evaluation for IVDS: Meeting Regulatory Expectations

Understanding the Importance of Clinical Performance Evaluation for IVDS: Meeting Regulatory Expectations Summary In vitro diagnostics (IVD) are tests that are carried out outside the human body to diagnose a wide range of illnesses and monitor various medical conditions. Importance of Clinical Performance Evaluation (CPE) for IVDS is essential for ensuring the accuracy and reliability


*All the above fields are mandatory
contact us 2
Enquire now